Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex Chronicus

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

August 1, 2024

Study Completion Date

August 30, 2024

Conditions

Lichen Simplex Chronicus

Interventions

DRUG

Betamethasone Valerate 0.1% Cream

Moderate potency

DEVICE

SmartXide® fractional carbon dioxide laser

Ablative

DRUG

Vaseline Topical Product

Emollient

Trial Locations (2)

Lobna Alieldin, Cairo

All Listed Sponsors

lead

Cairo University

OTHER

NCT06267066 - Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex Chronicus | Biotech Hunter | Biotech Hunter